Ace Therapeutics provides comprehensive solutions to clients worldwide developing boron neutron capture therapy (BNCT) for the treatment of liver disease. Our services are focused on optimizing BNCT for the treatment of liver cancer.
BNCT is a type of radiation therapy. It is a selective particle irradiation of tumor cells based on a nuclear reaction that selectively destroys tumor cells. It is currently used in clinical applications for invasive cancers. Hepatocellular carcinoma is the most common type of liver cancer and one of the most difficult cancers to treat. And BNCT provides effective potential therapy. Based on our advanced equipment and professional team, we aim to provide you with the most comprehensive preclinical study of BNCT for liver cancer.
What Can We Do?
As the research progresses, the therapeutic effect of BNCT in the field of cancer is gradually proven. Based on our professional team and advanced technology, we aim to provide perfect services to support the development of BNCT.
- In Vitro Evaluation of BNCT for Liver Cancer
The in vitro evaluation enables an initial assessment of the treatment approach. Therefore, we offer a comprehensive in vitro evaluation service for BNCT.
- Selection of HCC cell lines
We can provide different liver cancer cell lines to meet different research needs, such as SMMC-7721 human hepatocellular carcinoma cell line, Bel-7402 human hepatocellular carcinoma cell line, MHCC97 human hepatocellular carcinoma cell line, and HepG2 human hepatoblastoma.
- Experimental conditions optimization
Based on our hands-on experience, we will explore and optimize the boron uptake time course and quantification to determine the optimal experimental conditions based on your research project.
We will experiment with the specific characteristics of the project to screen the right boron carrier for your research.
- Therapeutic effect evaluation of BNCT for liver disease
We will perform a comprehensive analysis of hepatocellular carcinoma cell lines from different perspectives to evaluate the therapeutic effect of BNCT, such as cell activity, cell cycle, immunity, etc.
- In Vivo Evaluation of BNCT for Liver Cancer
In vivo studies allow for a more comprehensive assessment of aspects of BNCT such as efficacy and toxicity. Therefore, it is an important part of BNCT development. We provide high-quality and efficient services for the in vivo evaluation of BNCT.
- Our equipment allows real-time detection of the dynamics of the model animal to control the changes in the animal.
- We will screen for appropriate delivery of boron-containing drugs based on specific experimental projects.
- We will study the biodistribution of boron-containing drugs in animals to assess their effects and actions on the organism.
Based on our extensive hands-on experience, Ace Therapeutics can provide you with high-quality and efficient BNCT development services for the treatment of liver cancer. If you would like to learn more about our services, please feel free to contact us.
Related Services
Our products and services are for research use only and can not be used for diagnostic or other purposes.
